Rigel Pharmaceuticals (RIGL) EBIT (QoQ) (2010 - 2026)
Rigel Pharmaceuticals (RIGL) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Rigel Pharmaceuticals | 674.25 Mn | 527.57 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.71% |
| Dec 31, 2025 | -18.47% |
| Sep 30, 2025 | -53.49% |
| Jun 30, 2025 | 378.38% |
| Mar 31, 2025 | -23.31% |
| Dec 31, 2024 | 18.49% |
| Sep 30, 2024 | 3,044.52% |
| Jun 30, 2024 | 106.42% |
| Mar 31, 2024 | -454.32% |
| Dec 31, 2023 | 144.03% |
| Sep 30, 2023 | 15.23% |
| Jun 30, 2023 | 58.61% |
| Mar 31, 2023 | -712.07% |
| Dec 31, 2022 | 111.30% |
| Sep 30, 2022 | -41.94% |
| Jun 30, 2022 | 50.63% |
| Mar 31, 2022 | -22.61% |
| Dec 31, 2021 | -8.25% |
| Sep 30, 2021 | -51.63% |
| Jun 30, 2021 | -131.25% |